210 related articles for article (PubMed ID: 1534714)
21. Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension.
Lund-Johansen P; Omvik P
J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S139-48. PubMed ID: 2442506
[TBL] [Abstract][Full Text] [Related]
22. Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension.
Rofman BA
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S94-7. PubMed ID: 2467139
[TBL] [Abstract][Full Text] [Related]
23. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
24. Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension.
Omvik P; Lund-Johansen P; Haugland H
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S182-4. PubMed ID: 2455128
[TBL] [Abstract][Full Text] [Related]
25. Amlodipine: an effective once-daily antihypertensive agent.
Tyler HM
J Hum Hypertens; 1991 Aug; 5 Suppl 1():61-6. PubMed ID: 1834848
[TBL] [Abstract][Full Text] [Related]
26. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
27. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients.
Hernández R; Carvajal AR; Armas-de Hernández MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragán O; Machado-de Alvarado I
Postgrad Med J; 1991; 67 Suppl 5():S38-40. PubMed ID: 1839438
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of amlodipine dosing for conversion of nifedipine extended-release to amlodipine in the treatment of hypertension.
Yamreudeewong W; Halverson VJ; Lower DL; Kilpatrick DM; Enlow AM; Montopoli G
Ann Pharmacother; 1999 Jan; 33(1):7-10. PubMed ID: 9972377
[TBL] [Abstract][Full Text] [Related]
29. A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.
Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S103-6. PubMed ID: 2467116
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
Omvik P; Lund-Johansen P
Ann Clin Res; 1988; 20 Suppl 48():23-30. PubMed ID: 3250315
[TBL] [Abstract][Full Text] [Related]
31. Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus.
Lopez LM; Thorman AD; Mehta JL
Am J Cardiol; 1990 Nov; 66(17):1269-71. PubMed ID: 2146871
[No Abstract] [Full Text] [Related]
32. Comparison of daily anti-hypertensive effects of amlodipine and nifedipine coat-core using ambulatory blood pressure monitoring - utility of "hypobaric curve" and "hypobaric area".
Kuga K; Xu DZ; Ohtsuka M; Aonuma K; Lau AH; Watanabe Y; Ohtsuka K
Clin Exp Hypertens; 2011; 33(4):231-9. PubMed ID: 21699449
[TBL] [Abstract][Full Text] [Related]
33. Long-term haemodynamic effects of enalapril at rest and during exercise in essential hypertension.
Lund-Johansen P; Omvik P
Scand J Urol Nephrol Suppl; 1984; 79():87-91. PubMed ID: 6089323
[TBL] [Abstract][Full Text] [Related]
34. Long-term haemodynamic effects of sustained-release trimazosin at rest and during exercise in essential hypertension.
Omvik P; Lund-Johansen P
Eur J Clin Pharmacol; 1991; 40(2):131-4. PubMed ID: 2065694
[TBL] [Abstract][Full Text] [Related]
35. Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
Lund-Johansen P; Omvik P
Eur Heart J; 1992 Feb; 13(2):281-6. PubMed ID: 1555629
[TBL] [Abstract][Full Text] [Related]
36. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
[TBL] [Abstract][Full Text] [Related]
37. 24-hour blood pressure control with the once-daily calcium antagonist amlodipine.
Raftery EB; Heber ME; Brigden G; Al-Khawaja I
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S8-12. PubMed ID: 16296698
[TBL] [Abstract][Full Text] [Related]
38. A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients.
Mroczek WJ; Burris JF; Allenby KS
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S79-84. PubMed ID: 2467136
[TBL] [Abstract][Full Text] [Related]
39. Amlodipine and captopril in moderate-severe essential hypertension.
Maclean D; Mitchell ET; Wilcox RG; Walker P; Tyler HM
J Hum Hypertens; 1988 Aug; 2(2):127-32. PubMed ID: 2977406
[TBL] [Abstract][Full Text] [Related]
40. Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.
Lund-Johansen P; Omvik P; Haugland H
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):45S-54S. PubMed ID: 2939867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
